MDAI Stock Analysis: Why Spectral AI Inc. Scored 33% in Stock Value Finder

Spectral AI Inc. (MDAI): A Detailed Educational Stock Research Review

Overview of Spectral AI Inc. (MDAI)

Spectral AI Inc. (ticker: MDAI) is a healthcare company operating in the medical devices industry. This educational review from StockValueFinder.com examines the available financial metrics for MDAI to help investors understand how to evaluate stocks using objective, number-driven analysis. The goal is to provide clear, factual insights—not personal financial advice or predictions about future performance.

At the time of this review, MDAI has a StockValueFinder score of 33%, which corresponds to an "AVOID" rating. This score reflects a combination of financial metrics that suggest caution rather than immediate investment potential. Below, we break down each key metric to explain what the numbers mean, why they matter, and how they contribute to the overall assessment.

Why the StockValueFinder Score Matters

The StockValueFinder score is a composite measure designed to evaluate a company’s financial health, efficiency, valuation, and market trend. It ranges from 0% to 100%, with higher scores indicating stronger financial characteristics. A score of 33% places MDAI in the "AVOID" category, meaning the stock does not meet the minimum thresholds for quality, safety, or value based on the available data.

Scores are calculated using a weighted average of individual tests, including earnings consistency, return on invested capital (ROIC), interest coverage, debt payback, price-to-earnings (P/E) ratio, and moving average trends. Each test is assigned a pass or fail based on predefined benchmarks. While no single metric determines an investment’s success or failure, the combined score provides a structured way to compare stocks objectively.

EPS Strength and Consistency

What EPS Measures

Earnings per share (EPS) measures a company’s profitability on a per-share basis. Consistent or growing EPS over time is often a sign of a stable or improving business. Investors typically look for companies with a history of positive EPS, as this indicates the company is generating profits rather than losses.

StockValueFinder’s EPS Test

StockValueFinder evaluates EPS consistency as part of its financial health assessment. The system records whether a company has passed or failed this test based on historical earnings data. For MDAI, the EPS test result is "Did not pass." This means the company has not demonstrated the level of earnings consistency that StockValueFinder considers attractive for investment.

Why EPS Consistency Matters

EPS consistency is important because it reflects a company’s ability to generate profits reliably. For example, a company with EPS of $1.50, $1.60, and $1.70 over three consecutive years shows steady growth, which may indicate a well-managed business. In contrast, a company with volatile or negative EPS (e.g., -$0.50, $0.20, -$0.30) may face operational challenges or market instability.

Since the exact EPS values for MDAI are not supplied, we cannot analyze the specific earnings history. However, the "Did not pass" result suggests that the company’s earnings have not met the system’s criteria for consistency or positivity.

ROIC and Capital Efficiency

What ROIC Measures

Return on invested capital (ROIC) measures how effectively a company uses its capital to generate profits. It is calculated as:

**ROIC = (Net Operating Profit After Tax) / (Total Invested Capital)**

A higher ROIC indicates that a company is generating more profit from each dollar of capital invested. This metric is particularly useful for comparing companies within the same industry.

StockValueFinder’s ROIC Benchmark

StockValueFinder generally prefers companies with an ROIC of **10% or higher**. This threshold suggests that the company is using its capital efficiently and generating sufficient returns for shareholders. For example: – A company with an ROIC of 15% is typically more efficient than one with an ROIC of 4%. – An ROIC of 20% or higher is often considered excellent, indicating strong competitive advantages or high-margin businesses.

MDAI’s ROIC

MDAI’s ROIC is **-173.37%**. This is an extremely weak result and falls well below the 10% benchmark. A negative ROIC means the company is losing money on its invested capital, which is a red flag for investors. It suggests that the company’s operations are not generating enough profit to cover the cost of its capital, which could be due to high expenses, low revenue, or inefficient asset utilization.

Why ROIC Matters

ROIC is a critical metric because it reveals how well a company is deploying its resources. For example: – A medical device company with an ROIC of 12% is likely generating healthy returns from its R&D and manufacturing investments. – A company with an ROIC of -50% may be struggling with high production costs, low sales, or excessive debt.

MDAI’s ROIC of -173.37% indicates significant inefficiency or operational challenges, which is why it failed the ROIC test.

Interest Coverage and Financial Safety

What Interest Coverage Measures

Interest coverage measures a company’s ability to pay the interest on its debt. It is calculated as:

**Interest Coverage = (Earnings Before Interest and Taxes) / (Interest Expense)**

A higher interest coverage ratio indicates that a company can comfortably meet its interest obligations, while a low or negative ratio suggests financial strain.

StockValueFinder’s Interest Coverage Benchmark

StockValueFinder prefers companies with an interest coverage ratio of **6 or higher**. This threshold indicates that the company generates enough earnings to cover its interest payments at least six times over. For example: – A company with interest coverage of 8x is in a stronger financial position than one with 2x coverage. – A ratio below 1x means the company is not generating enough earnings to cover its interest expenses, which is a sign of financial distress.

MDAI’s Interest Coverage

MDAI’s interest coverage test result is "Did not pass." This means the company’s interest coverage ratio does not meet the system’s minimum threshold of 6. While the exact interest coverage number is not supplied, the "Did not pass" result suggests that MDAI may be struggling to generate sufficient earnings to cover its debt obligations.

Why Interest Coverage Matters

Interest coverage is a key indicator of financial safety. For example

– A company with interest coverage of 10x can easily service its debt, even if earnings decline slightly. – A company with interest coverage of 1.5x may face difficulties if earnings drop or interest rates rise.

Since MDAI failed this test, investors should be cautious about the company’s ability to manage its debt load.

Debt Payback and Balance Sheet Discipline

What Debt Payback Measures

Debt payback measures how long it would take a company to pay off its total debt using its current operating income. It is calculated as:

**Debt Payback Years = (Total Debt) / (Operating Income)**

A shorter debt payback period indicates a stronger balance sheet and lower financial risk.

StockValueFinder’s Debt Payback Benchmark

StockValueFinder prefers companies with a debt payback period of **3 years or less**. This suggests that the company can repay its debt relatively quickly using its operating income. For example: – A company with a debt payback period of 1.5 years is in a stronger position than one with 7 years. – A negative debt payback period (as seen with MDAI) indicates that the company is not generating positive operating income, making it impossible to repay debt under current conditions.

MDAI’s Debt Payback

MDAI’s debt payback period is **-0.56 years**. While this number is unusual, the negative sign indicates that the company is not generating positive operating income. This is why the system marked the debt payback test as "Passed"—not because the number is attractive, but because the test is designed to flag companies with excessively long debt payback periods (e.g., 10+ years). Since MDAI’s debt payback is negative, it technically passes this test, but the result is still concerning.

Why Debt Payback Matters

Debt payback is important because it reveals a company’s ability to manage its obligations. For example: – A company with a debt payback period of 2 years can quickly reduce its debt load, freeing up cash for growth or shareholder returns. – A company with a debt payback period of 15 years may struggle to service its debt, especially in a rising interest rate environment.

While MDAI passed this test, the negative debt payback period is a significant red flag, as it suggests the company is not generating enough income to cover its debt.

P/E Ratio and Valuation Discipline

What P/E Ratio Measures

The price-to-earnings (P/E) ratio measures a company’s current stock price relative to its earnings per share. It is calculated as:

**P/E Ratio = (Stock Price) / (Earnings Per Share)**

A lower P/E ratio may indicate that a stock is undervalued, while a higher P/E ratio may suggest overvaluation. However, P/E ratios must be interpreted in the context of the company’s growth prospects, industry norms, and overall financial health.

StockValueFinder’s P/E Benchmark

StockValueFinder prefers companies with a P/E ratio of **15 or lower** for valuation discipline. This threshold helps identify stocks that may be trading at reasonable prices relative to their earnings. For example: – A company with a P/E of 8 may be more attractively valued than one with a P/E of 40, assuming both companies have similar growth prospects and financial health. – A negative P/E ratio (as seen with MDAI) indicates that the company is not profitable, making the P/E ratio meaningless for valuation purposes.

MDAI’s P/E Ratio

MDAI’s P/E ratio is **-4.84**. This negative P/E ratio means the company is currently unprofitable, as it is generating negative earnings. While the system marked the P/E valuation test as "Passed," this is not because the P/E ratio is attractive. Instead, the test is designed to flag companies with excessively high P/E ratios (e.g., 50+), which may indicate overvaluation. Since MDAI’s P/E is negative, it technically passes this test, but the result is not meaningful for valuation purposes.

Why P/E Ratio Matters

The P/E ratio is a widely used metric for assessing valuation. For example

– A company with a P/E of 12 may be considered reasonably valued if its industry peers trade at similar levels. – A company with a P/E of 30 may be overvalued unless it has exceptional growth prospects.

For MDAI, the negative P/E ratio is a clear sign that the company is not profitable, which is a significant risk for investors.

Moving Average Trend and Entry Timing

What Moving Averages Measure

Moving averages are technical indicators that smooth out price data to identify trends. StockValueFinder uses moving averages to assess whether a stock is in an uptrend, downtrend, or sideways trend. This helps investors understand the stock’s momentum and potential timing for entry or exit.

StockValueFinder’s Moving Average Signal

StockValueFinder’s moving average signal for MDAI is "SELL / AVOID TREND." This indicates that the stock is in a downtrend or showing weak momentum. The system also lists the entry signal as "N/A," meaning there is no favorable entry point identified at this time.

Why Moving Average Trends Matter

Moving average trends are useful for timing discipline. For example

– A stock trading above its 50-day and 200-day moving averages may be in an uptrend, suggesting bullish momentum. – A stock trading below its moving averages may be in a downtrend, indicating bearish momentum.

MDAI’s "SELL / AVOID TREND" signal suggests that the stock is not in a favorable trend, which aligns with the overall "AVOID" rating.

Overall Financial Strengths and Weaknesses

Strengths

1. **Debt Payback Test Passed**: While MDAI’s debt payback period is negative, the system’s test is designed to flag excessively long payback periods (e.g., 10+ years). Since MDAI’s debt payback is negative, it technically passes this test. 2. **P/E Valuation Test Passed**: Similarly, the P/E test is designed to flag excessively high P/E ratios. Since MDAI’s P/E is negative, it technically passes this test, though the result is not meaningful for valuation.

Weaknesses

1. **EPS Test Failed**: MDAI did not pass the EPS consistency test, indicating a lack of reliable profitability. 2. **ROIC Test Failed**: With an ROIC of -173.37%, MDAI is highly inefficient in using its capital to generate profits. 3. **Interest Coverage Test Failed**: The company’s interest coverage does not meet the system’s minimum threshold, suggesting financial strain. 4. **Negative P/E Ratio**: The negative P/E ratio confirms that MDAI is not profitable. 5. **Negative Debt Payback**: While the test was passed, the negative debt payback period is a significant red flag. 6. **SELL / AVOID TREND**: The moving average signal indicates weak momentum and a downtrend.

Risks and Limitations

Financial Risks

1. **Negative Profitability**: MDAI’s negative P/E ratio and ROIC indicate that the company is not generating profits. This is a significant risk, as unprofitable companies may struggle to sustain operations, service debt, or fund growth. 2. **High Debt Levels**: While the debt payback test was passed, the negative debt payback period suggests that MDAI is not generating enough income to cover its debt obligations. This could lead to financial distress if the company’s financial situation does not improve. 3. **Weak Interest Coverage**: The failed interest coverage test indicates that MDAI may have difficulty meeting its interest payments, which could lead to default or bankruptcy if earnings do not improve.

Market Risks

1. **Downtrend Signal**: The "SELL / AVOID TREND" moving average signal suggests that MDAI is in a downtrend. Investors should be cautious about entering a position in a stock with weak momentum. 2. **Low Stock Price**: MDAI’s recent price of $1.50 places it in the micro-cap or penny stock category. Stocks in this range are often more volatile and may carry higher risk.

Industry Risks

1. **Medical Devices Sector**: The medical devices industry is highly competitive and regulated. Companies in this sector often face significant R&D costs, regulatory hurdles, and pricing pressures. MDAI’s financial struggles may be partly due to these industry challenges. 2. **Healthcare Sector Volatility**: The healthcare sector can be volatile due to changes in government policies, insurance reimbursement rates, and technological advancements. These factors can impact MDAI’s revenue and profitability.

Limitations of This Analysis

1. **Lack of Detailed Financial Data**: This review is based on the supplied metrics, which do not include detailed financial statements, cash flow data, or management commentary. A deeper analysis would require access to these additional data points. 2. **No Forward-Looking Information**: This review does not include analyst estimates, future earnings projections, or upcoming product launches. These factors could significantly impact MDAI’s future performance. 3. **No Comparison to Peers**: This analysis does not compare MDAI to its industry peers. A peer comparison could provide additional context for evaluating the company’s financial health and valuation.

Educational Conclusion

This educational review of Spectral AI Inc. (MDAI) provides a structured, number-driven analysis of the company’s financial metrics. The goal is to help investors understand how to evaluate stocks using objective criteria, not to make predictions or recommendations.

Key Takeaways

1. **StockValueFinder Score**: MDAI’s score of 33% and "AVOID" rating reflect significant financial weaknesses, including negative profitability, inefficient capital use, and weak interest coverage. 2. **EPS Consistency**: The company failed the EPS test, indicating a lack of reliable earnings. 3. **ROIC**: With an ROIC of -173.37%, MDAI is highly inefficient in generating returns on its invested capital. 4. **Interest Coverage**: The failed interest coverage test suggests financial strain and difficulty meeting debt obligations. 5. **Debt Payback**: While the test was passed, the negative debt payback period is a red flag. 6. **P/E Ratio**: The negative P/E ratio confirms that MDAI is not profitable. 7. **Moving Average Trend**: The "SELL / AVOID TREND" signal indicates weak momentum and a downtrend.

How to Use This Analysis

This review is designed to educate investors on how to evaluate stocks using financial metrics. Here are some key lessons: 1. **Earnings Matter**: Consistent or growing EPS is a sign of a healthy business. Companies with negative or volatile EPS may face operational challenges. 2. **Capital Efficiency**: ROIC reveals how well a company uses its capital. A negative ROIC is a warning sign. 3. **Debt Management**: Interest coverage and debt payback periods help assess a company’s ability to manage its obligations. Weak results in these areas can indicate financial distress. 4. **Valuation Discipline**: The P/E ratio helps assess whether a stock is reasonably priced. A negative P/E ratio is a clear sign of unprofitability. 5. **Trend Awareness**: Moving average trends provide insight into a stock’s momentum. A "SELL / AVOID TREND" signal suggests caution.

Final Thoughts

MDAI’s financial metrics reveal significant challenges, including negative profitability, inefficient capital use, and weak interest coverage. While the company passed the debt payback and P/E valuation tests, these results are not meaningful due to the negative values. The "AVOID" rating and 33% score reflect these weaknesses and suggest that MDAI may not be a suitable investment for most investors at this time.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.

---

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings